South Korea Cold Chain & Pharma Logistics Market

The South Korea cold chain & pharma logistics market, valued at USD 5 billion, is growing due to rising pharmaceutical needs, e-commerce, and government initiatives for efficient logistics.

Region:Asia

Author(s):Shubham

Product Code:KRAB6604

Pages:95

Published On:October 2025

About the Report

Base Year 2024

South Korea Cold Chain & Pharma Logistics Market Overview

  • The South Korea Cold Chain & Pharma Logistics Market is valued at USD 5 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for temperature-sensitive pharmaceuticals and the expansion of the healthcare sector, which necessitates efficient logistics solutions to maintain product integrity throughout the supply chain.
  • Seoul, Busan, and Incheon are the dominant cities in this market due to their strategic locations, advanced infrastructure, and proximity to major pharmaceutical companies and healthcare facilities. These cities serve as key logistics hubs, facilitating efficient distribution and storage of temperature-sensitive products.
  • In 2023, the South Korean government implemented regulations mandating that all pharmaceutical products requiring cold chain logistics must adhere to strict temperature control standards. This regulation aims to enhance product safety and efficacy, ensuring that temperature-sensitive medications are stored and transported under optimal conditions.
South Korea Cold Chain & Pharma Logistics Market Size

South Korea Cold Chain & Pharma Logistics Market Segmentation

By Type:The market is segmented into various types, including Refrigerated Transport, Cold Storage Facilities, Packaging Solutions, Monitoring Systems, and Others. Each of these segments plays a crucial role in ensuring the integrity of temperature-sensitive products throughout the supply chain.

South Korea Cold Chain & Pharma Logistics Market segmentation by Type.

By End-User:The end-user segmentation includes Pharmaceuticals, Biotechnology, Clinical Trials, Healthcare Providers, and Others. Each segment reflects the diverse applications of cold chain logistics in maintaining the quality and safety of temperature-sensitive products.

South Korea Cold Chain & Pharma Logistics Market segmentation by End-User.

South Korea Cold Chain & Pharma Logistics Market Competitive Landscape

The South Korea Cold Chain & Pharma Logistics Market is characterized by a dynamic mix of regional and international players. Leading participants such as CJ Logistics, Hanjin Transportation, Lotte Global Logistics, SK Networks, Hyundai Glovis, DB Schenker, Kuehne + Nagel, DSV Panalpina, XPO Logistics, Nippon Express, Agility Logistics, Panalpina, Geodis, Expeditors International, Sinotrans Limited contribute to innovation, geographic expansion, and service delivery in this space.

CJ Logistics

1930

Seoul, South Korea

Hanjin Transportation

1945

Seoul, South Korea

Lotte Global Logistics

2013

Seoul, South Korea

SK Networks

1953

Seoul, South Korea

Hyundai Glovis

2001

Seoul, South Korea

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Operational Efficiency

Delivery Accuracy

South Korea Cold Chain & Pharma Logistics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Temperature-Sensitive Pharmaceuticals:The South Korean pharmaceutical market is projected to reach approximately $30 billion in the future, driven by a surge in demand for temperature-sensitive products. The rise in chronic diseases and an aging population, which is expected to reach 9.5 million in the future, necessitates efficient cold chain logistics to ensure drug efficacy and safety. This growing demand is a significant driver for enhancing cold chain capabilities in the region.
  • Expansion of E-commerce in the Pharmaceutical Sector:E-commerce sales in South Korea's pharmaceutical sector are anticipated to exceed $5 billion in the future, reflecting a robust growth trajectory. The convenience of online purchasing, coupled with the increasing consumer preference for home delivery of medications, is propelling the need for efficient cold chain logistics. This trend necessitates advanced logistics solutions to maintain product integrity during transit, thereby driving market growth.
  • Government Initiatives to Enhance Healthcare Logistics:The South Korean government has allocated approximately $1.2 billion for healthcare logistics improvements in the future. This investment aims to bolster cold chain infrastructure, ensuring compliance with stringent regulations. Initiatives include the establishment of temperature-controlled warehouses and transportation systems, which are crucial for maintaining the quality of pharmaceuticals. Such government support is a vital growth driver for the cold chain logistics market.

Market Challenges

  • High Operational Costs Associated with Cold Chain Logistics:The operational costs for cold chain logistics in South Korea are estimated to be around $2.5 billion annually. These costs stem from the need for specialized equipment, energy consumption for temperature control, and skilled labor. Such high expenses can deter smaller companies from entering the market, limiting competition and innovation within the sector.
  • Regulatory Compliance Complexities:South Korea's stringent regulatory environment imposes significant compliance costs, estimated at $500 million annually for logistics providers. Regulations such as Good Distribution Practice (GDP) require rigorous adherence to temperature control and documentation standards. Navigating these complexities can be challenging for companies, particularly smaller firms lacking the resources to ensure compliance, thus posing a barrier to market entry.

South Korea Cold Chain & Pharma Logistics Market Future Outlook

The future of the South Korean cold chain and pharma logistics market appears promising, driven by technological advancements and increasing consumer expectations for drug safety. The integration of IoT and AI technologies is expected to enhance tracking and monitoring capabilities, improving operational efficiency. Additionally, the focus on sustainability will likely lead to the adoption of eco-friendly practices, further shaping the logistics landscape. These trends indicate a dynamic evolution in the market, fostering innovation and growth.

Market Opportunities

  • Technological Advancements in Tracking and Monitoring:The implementation of advanced tracking technologies, such as blockchain and IoT, presents a significant opportunity for enhancing supply chain transparency. In the future, investments in these technologies are expected to reach $300 million, improving real-time monitoring and reducing spoilage rates, thus benefiting logistics providers and pharmaceutical companies alike.
  • Growth in Biopharmaceuticals and Personalized Medicine:The biopharmaceutical sector in South Korea is projected to grow to $10 billion in the future, creating a substantial demand for specialized cold chain logistics. This growth presents opportunities for logistics providers to develop tailored solutions that cater to the unique requirements of biopharmaceuticals, including temperature-sensitive storage and transportation, thereby enhancing service offerings.

Scope of the Report

SegmentSub-Segments
By Type

Refrigerated Transport

Cold Storage Facilities

Packaging Solutions

Monitoring Systems

Others

By End-User

Pharmaceuticals

Biotechnology

Clinical Trials

Healthcare Providers

Others

By Distribution Mode

Road Transport

Air Transport

Sea Transport

Rail Transport

Others

By Application

Vaccines

Blood Products

Biologics

Medical Devices

Others

By Sales Channel

Direct Sales

Distributors

Online Sales

Retail

Others

By Price Range

Premium

Mid-Range

Budget

Others

By Policy Support

Subsidies

Tax Exemptions

Grants

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Food and Drug Safety, Korea Customs Service)

Pharmaceutical Manufacturers

Cold Chain Logistics Providers

Healthcare Institutions

Biotechnology Companies

Supply Chain Management Firms

Pharmaceutical Wholesalers

Players Mentioned in the Report:

CJ Logistics

Hanjin Transportation

Lotte Global Logistics

SK Networks

Hyundai Glovis

DB Schenker

Kuehne + Nagel

DSV Panalpina

XPO Logistics

Nippon Express

Agility Logistics

Panalpina

Geodis

Expeditors International

Sinotrans Limited

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. South Korea Cold Chain & Pharma Logistics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 South Korea Cold Chain & Pharma Logistics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. South Korea Cold Chain & Pharma Logistics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for temperature-sensitive pharmaceuticals
3.1.2 Expansion of e-commerce in the pharmaceutical sector
3.1.3 Government initiatives to enhance healthcare logistics
3.1.4 Rising consumer awareness regarding drug safety

3.2 Market Challenges

3.2.1 High operational costs associated with cold chain logistics
3.2.2 Regulatory compliance complexities
3.2.3 Limited infrastructure in rural areas
3.2.4 Competition from alternative logistics solutions

3.3 Market Opportunities

3.3.1 Technological advancements in tracking and monitoring
3.3.2 Growth in biopharmaceuticals and personalized medicine
3.3.3 Strategic partnerships with healthcare providers
3.3.4 Expansion into emerging markets

3.4 Market Trends

3.4.1 Adoption of IoT and AI in logistics management
3.4.2 Increasing focus on sustainability in logistics
3.4.3 Shift towards integrated supply chain solutions
3.4.4 Growth of automated cold storage facilities

3.5 Government Regulation

3.5.1 Strict temperature control regulations for pharmaceuticals
3.5.2 Compliance with Good Distribution Practice (GDP)
3.5.3 Regulations on transportation of hazardous materials
3.5.4 Incentives for investment in cold chain infrastructure

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. South Korea Cold Chain & Pharma Logistics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. South Korea Cold Chain & Pharma Logistics Market Segmentation

8.1 By Type

8.1.1 Refrigerated Transport
8.1.2 Cold Storage Facilities
8.1.3 Packaging Solutions
8.1.4 Monitoring Systems
8.1.5 Others

8.2 By End-User

8.2.1 Pharmaceuticals
8.2.2 Biotechnology
8.2.3 Clinical Trials
8.2.4 Healthcare Providers
8.2.5 Others

8.3 By Distribution Mode

8.3.1 Road Transport
8.3.2 Air Transport
8.3.3 Sea Transport
8.3.4 Rail Transport
8.3.5 Others

8.4 By Application

8.4.1 Vaccines
8.4.2 Blood Products
8.4.3 Biologics
8.4.4 Medical Devices
8.4.5 Others

8.5 By Sales Channel

8.5.1 Direct Sales
8.5.2 Distributors
8.5.3 Online Sales
8.5.4 Retail
8.5.5 Others

8.6 By Price Range

8.6.1 Premium
8.6.2 Mid-Range
8.6.3 Budget
8.6.4 Others

8.7 By Policy Support

8.7.1 Subsidies
8.7.2 Tax Exemptions
8.7.3 Grants
8.7.4 Others

9. South Korea Cold Chain & Pharma Logistics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Operational Efficiency
9.2.7 Delivery Accuracy
9.2.8 Pricing Strategy
9.2.9 Service Level Agreements Compliance
9.2.10 Inventory Turnover Rate

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 CJ Logistics
9.5.2 Hanjin Transportation
9.5.3 Lotte Global Logistics
9.5.4 SK Networks
9.5.5 Hyundai Glovis
9.5.6 DB Schenker
9.5.7 Kuehne + Nagel
9.5.8 DSV Panalpina
9.5.9 XPO Logistics
9.5.10 Nippon Express
9.5.11 Agility Logistics
9.5.12 Panalpina
9.5.13 Geodis
9.5.14 Expeditors International
9.5.15 Sinotrans Limited

10. South Korea Cold Chain & Pharma Logistics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health and Welfare
10.1.2 Ministry of Food and Drug Safety
10.1.3 Ministry of Trade, Industry and Energy

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Cold Chain Facilities
10.2.2 Spending on Technology Upgrades
10.2.3 Budget Allocation for Compliance

10.3 Pain Point Analysis by End-User Category

10.3.1 Pharmaceutical Companies
10.3.2 Hospitals and Clinics
10.3.3 Research Institutions

10.4 User Readiness for Adoption

10.4.1 Awareness of Cold Chain Importance
10.4.2 Training and Skill Development
10.4.3 Infrastructure Readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Cost Savings
10.5.2 Expansion of Service Offerings
10.5.3 Customer Satisfaction Metrics

11. South Korea Cold Chain & Pharma Logistics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Solutions

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership Considerations

12.2 Partnerships Evaluation


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability Strategies


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from South Korean logistics associations and pharmaceutical bodies
  • Review of government publications on cold chain regulations and healthcare logistics
  • Examination of market trends through academic journals and white papers on cold chain management

Primary Research

  • Interviews with logistics managers at major pharmaceutical companies operating in South Korea
  • Surveys with cold chain service providers to gather insights on operational challenges
  • Field interviews with regulatory experts to understand compliance requirements in pharma logistics

Validation & Triangulation

  • Cross-validation of data through multiple sources including trade publications and industry surveys
  • Triangulation of findings from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel discussions with industry veterans

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total logistics spending in South Korea with a focus on cold chain segments
  • Segmentation of the market by pharmaceutical categories and temperature-sensitive products
  • Incorporation of government initiatives aimed at enhancing cold chain infrastructure

Bottom-up Modeling

  • Collection of operational data from leading cold chain logistics providers
  • Cost analysis based on service pricing models for temperature-controlled transport
  • Volume estimates derived from pharmaceutical distribution channels and sales data

Forecasting & Scenario Analysis

  • Multi-variable forecasting using growth rates in the pharmaceutical sector and cold chain advancements
  • Scenario planning based on potential regulatory changes and technological innovations
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Cold Chain Logistics150Logistics Managers, Supply Chain Analysts
Temperature-Controlled Transport Services100Operations Directors, Fleet Managers
Pharma Warehousing Solutions80Warehouse Managers, Compliance Officers
Regulatory Compliance in Pharma Logistics70Regulatory Affairs Specialists, Quality Assurance Managers
Cold Chain Technology Providers90Product Development Managers, Technology Officers

Frequently Asked Questions

What is the current value of the South Korea Cold Chain & Pharma Logistics Market?

The South Korea Cold Chain & Pharma Logistics Market is valued at approximately USD 5 billion, driven by the increasing demand for temperature-sensitive pharmaceuticals and the expansion of the healthcare sector, which requires efficient logistics solutions to maintain product integrity.

Which cities are key logistics hubs in South Korea for cold chain and pharma logistics?

What regulations has the South Korean government implemented regarding cold chain logistics?

What are the main segments of the South Korea Cold Chain & Pharma Logistics Market?

Other Adjacent Reports

Saudi Arabia Pharmaceutical Manufacturing Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

South Africa Biotechnology Products Market

South Korea Clinical Trials Services Market

Indonesia Healthcare Supply Chain Market

Philippines Temperature-Controlled Packaging Market

Mexico Refrigerated Transportation Market

South Africa Logistics Monitoring Systems Market

UAE E-commerce Pharmaceutical Delivery Market

Malaysia Biopharmaceutical Logistics Market

UAE Sustainable Logistics Solutions Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022